Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 3/20 | 0.84 |
| ▸ | CASP2 | P42575 | 1/20 | 0.61 |
| ▸ | FAAH | O00519 | 5/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.52 |
| ▸ | THRA | P10827 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22907946 | 1.00 | DNM1 (0.84) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL22907873 | 1.00 | DNM1 (0.84) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL22907872 | 1.00 | DNM1 (0.84) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL21419343 | 1.00 | DNM1 (0.84) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL21419344 | 0.97 | DNM1 (0.84) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL1601857 | 0.97 | DNM1 (0.90) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL9549112 | 0.97 | DNM1 (0.90) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL1603004 | 0.97 | DNM1 (0.90) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL19479185 | 0.97 | DNM1 (0.90) | DNM1CASP2FAAHNAAAEPHX2 | |
| SCHEMBL9665089 | 0.97 | DNM1 (0.90) | DNM1CASP2FAAHNAAAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210017124-A1 | THICKENING STABILIZER AND SOLVENT COMPOSITION USING SAME FOR PRODUCING ELECTRONIC DEVICE | DAICEL CORPORATION (JP) | 2021-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210017124-A1 | THICKENING STABILIZER AND SOLVENT COMPOSITION USING SAME FOR PRODUCING ELECTRONIC DEVICE | HRH3, HRH1, H1-0 | DNM1 2464/4885CASP2 4273/4885FAAH 63/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.